Citigroup’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,404,598
| Closed | -$809M | – | 6594 |
|
|
2021
Q2 | $809M | Buy |
4,404,598
+1,122,326
| +34% | +$193M | 0.71% | 31 |
|
|
2021
Q1 | $502M | Buy |
3,282,272
+2,159,567
| +192% | +$334M | 0.48% | 47 |
|
|
2020
Q4 | $175M | Buy |
1,122,705
+279,199
| +33% | +$35.9M | 0.19% | 167 |
|
|
2020
Q3 | $96.5M | Buy |
843,506
+48,713
| +6% | +$5.26M | 0.12% | 251 |
|
|
2020
Q2 | $89.2M | Buy |
794,793
+69,687
| +10% | +$7.4M | 0.13% | 242 |
|
|
2020
Q1 | $65.1M | Sell |
725,106
-23,917
| -3% | -$2.35M | 0.12% | 279 |
|
|
2019
Q4 | $81M | Sell |
749,023
-61,973
| -8% | -$6.63M | 0.11% | 309 |
|
|
2019
Q3 | $79.4M | Buy |
810,996
+144,525
| +22% | +$16.3M | 0.12% | 299 |
|
|
2019
Q2 | $87.3M | Buy |
666,471
+228,725
| +52% | +$29.5M | 0.13% | 263 |
|
|
2019
Q1 | $59.2M | Buy |
437,746
+167,921
| +62% | +$20.9M | 0.11% | 336 |
|
|
2018
Q4 | $26.3M | Buy |
269,825
+60,562
| +29% | +$7.16M | 0.05% | 670 |
|
|
2018
Q3 | $29.1M | Buy |
209,263
+30,599
| +17% | +$3.84M | 0.05% | 625 |
|
|
2018
Q2 | $22.2M | Sell |
178,664
-38,036
| -18% | -$4.45M | 0.04% | 744 |
|
|
2018
Q1 | $24.2M | Buy |
216,700
+68,262
| +46% | +$8.16M | 0.04% | 689 |
|
|
2017
Q4 | $17.8M | Buy |
148,438
+24,325
| +20% | +$2.96M | 0.03% | 910 |
|
|
2017
Q3 | $17.4M | Sell |
124,113
-17,882
| -13% | -$2.43M | 0.03% | 866 |
|
|
2017
Q2 | $17.3M | Buy |
141,995
+56,894
| +67% | +$6.62M | 0.04% | 834 |
|
|
2017
Q1 | $10.3M | Sell |
85,101
-83,309
| -49% | -$10.7M | 0.02% | 1114 |
|
|
2016
Q4 | $20.6M | Buy |
168,410
+111,509
| +196% | +$13.6M | 0.04% | 761 |
|
|
2016
Q3 | $6.97M | Buy |
56,901
+7,202
| +14% | +$927K | 0.02% | 1364 |
|
|
2016
Q2 | $5.8M | Sell |
49,699
-3,972
| -7% | -$564K | 0.01% | 1442 |
|
|
2016
Q1 | $7.47M | Buy |
53,671
+7,344
| +16% | +$1.08M | 0.02% | 1216 |
|
|
2015
Q4 | $8.84M | Sell |
46,327
-68,947
| -60% | -$12M | 0.02% | 1247 |
|
|
2015
Q3 | $18M | Sell |
115,274
-12,404
| -10% | -$2.26M | 0.04% | 765 |
|
|
2015
Q2 | $23.1M | Buy |
127,678
+27,701
| +28% | +$4.78M | 0.04% | 707 |
|
|
2015
Q1 | $17.3M | Buy |
99,977
+14,340
| +17% | +$2.6M | 0.03% | 850 |
|
|
2014
Q4 | $15.8M | Buy |
85,637
+23,827
| +39% | +$4.42M | 0.03% | 935 |
|
|
2014
Q3 | $10.3M | Sell |
61,810
-20,067
| -25% | -$3.3M | 0.02% | 1264 |
|
|
2014
Q2 | $12.8M | Buy |
81,877
+1,366
| +2% | +$216K | 0.02% | 1094 |
|
|
2014
Q1 | $12.2M | Sell |
80,511
-118,639
| -60% | -$18.9M | 0.02% | 1017 |
|
|
2013
Q4 | $26.5M | Buy |
199,150
+709
| +0.4% | +$85.1K | 0.05% | 631 |
|
|
2013
Q3 | $23.1M | Sell |
198,441
-2,573
| -1% | -$282K | 0.04% | 672 |
|
|
2013
Q2 | $18.5M | Buy |
+201,014
| New | +$19.4M | 0.04% | 718 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM